Jean M. Tersak, MD, provides care for pediatric oncology patients and long term survivors of childhood cancer at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is institutional principal investigator for the UPMC Children’s Oncology Group and director of clinical oncology research within the Division of Pediatric Hematology/Oncology. She is also a professor of pediatrics and clinical and translational science at the University of Pittsburgh School of Medicine and is board-certified in pediatric hematology/oncology. Dr. Tersak earned her bachelor's degree, master’s degree, and  medical degree from the University of Pittsburgh. She completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis. Her research interests include the late effects, quality of life, and neurocognitive outcomes in survivors of childhood cancer and evaluation and treatment of opsoclonus myoclonus in patients with neuroblastoma. She is a member of the American Society of Clinical Oncology Children’s Oncology Group. View the full list of Dr. Tersak’s publications on PubMed. Dr. Tersak is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroepithelioma, Neuroblastoma, Histiocytosis, Bone Marrow Aspiration, and Splenectomy.

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. Dr. Ruiz is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, Chondrosarcoma, and Gamma Knife Radiosurgery.

Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Cataract Removal, and Gamma Knife Radiosurgery.

Julia Segal is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Histiocytosis, Reticulohistiocytoma, Neuroblastoma, and Hemophagocytic Lymphohistiocytosis.

Leonard Appleman is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Appleman is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

Alisa Goldstein is a primary care provider, practicing in Family Medicine in Pittsburgh, Pennsylvania. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Hirschsprung Disease, Chordoma, Esophageal Cancer, Stomach Cancer, and Parathyroidectomy.

Jennifer Osborn, MD, specializes in hematology oncology and is board-certified in medical oncology by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center at UPMC Passavant-McCandless and UPMC Hillman Cancer Center at UPMC Passavant-Cranberry and is affiliated with UPMC Passavant and UPMC Magee-Womens Hospital. Dr. Osborn received her medical degree from The Ohio State University College of Medicine and completed her residency and fellowship at the University of Pittsburgh School of Medicine. Dr. Osborn is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Helena Levitt, MD, is board-certified in endocrinology, diabetes, and metabolism by the American Board of Internal Medicine. She practices at UPMC Center for Diabetes and Endocrinology and is affiliated with UPMC Williamsport, UPMC Muncy, UPMC Presbyterian, and UPMC Magee-Womens Hospital. Dr. Levitt completed her medical degree and fellowship at the University of Pittsburgh School of Medicine and residency at the University of Virginia School of Medicine. Dr. Levitt is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Postmenopausal Osteoporosis, and Osteoporosis.

Boriana Kamenova is a Hematologist Oncology specialist and a Hematologist in Monroeville, Pennsylvania. Dr. Kamenova is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Anemia, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Kamenova is currently accepting new patients.